4.8 Article

The human gut bacterial genotoxin colibactin alkylates DNA

Journal

SCIENCE
Volume 363, Issue 6428, Pages 709-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aar7785

Keywords

-

Funding

  1. Packard Fellowship for Science and Engineering
  2. Damon Runyon-Rachleff Innovation Award
  3. National Institutes of Health [R01 CA208834, R01 CA154426, R01 ES022872]
  4. National Institute of Environmental Health Sciences [R44 ES024698]
  5. Center for Environmental Health Sciences [P30 ES002109]
  6. National Cancer Institute [R50-CA211256]
  7. U.S. National Institutes of Health
  8. National Cancer Institute (Cancer Center Support Grant) [CA-77598]
  9. American Cancer Society-New England Division Postdoctoral Fellowship [PF-16-122-01-CDD]

Ask authors/readers for more resources

Certain Escherichia coli strains residing in the human gut produce colibactin, a small-molecule genotoxin implicated in colorectal cancer pathogenesis. However, colibactin's chemical structure and the molecular mechanism underlying its genotoxic effects have remained unknown for more than a decade. Here we combine an untargeted DNA adductomics approach with chemical synthesis to identify and characterize a covalent DNA modification from human cell lines treated with colibactin-producing E. coli. Our data establish that colibactin alkylates DNA with an unusual electrophilic cyclopropane. We show that this metabolite is formed in mice colonized by colibactin-producing E. coli and is likely derived from an initially formed, unstable colibactin-DNA adduct. Our findings reveal a potential biomarker for colibactin exposure and provide mechanistic insights into how a gut microbe may contribute to colorectal carcinogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available